ORGO Sınıf A Organogenesis Holdings Inc. - Class A
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$1,33
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$1,3252 haftanın en düşüğü
$7,0852 haftanın en yükseği
Piyasa Değeri (MRQ)
$171M
P/E (TTM)
-1.7
Hisse Başına Kâr (TTM)
$-0.79
Gelir (TTM)
$457M
rozetleriniz
52 Haftlık Aralık
$1–$7
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$2
P/E
-1.7
ROE
-44.1%
Net Kâr Marjı
-18.4%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ORGO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.33
Piyasa Değeri (MRQ)
$171M
P/E (TTM)
-1.7
Hisse Başına Kâr (TTM)
$-0.79
Gelir (TTM)
$457M
ROE (TTM)
-44.1%
52 Haftlık Aralık
$1–$7
ORGO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$564M2016-12-31 → 2025-12-31
Hisse Başına Kâr$0.152018-12-31 → 2025-12-31
Serbest Nakit Akışı$-24M2022-12-31 → 2025-12-31
Net kar marjı-18.4%2022-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ORGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.75Y ort. ≈-29.5 | ≈-29.5 | · | · | |
| F/S (TTM) | 0.45Y ort. ≈1.1 | ≈1.1 | 6.4 | Düşük değerli | |
| F/D (MRQ) | 1.25Y ort. ≈1.8 | ≈1.8 | 1.9 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | 8.25Y ort. ≈5.4 | ≈5.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 5.45Y ort. ≈-10.8 | ≈-10.8 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 1.25Y ort. ≈2.9 | ≈2.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ORGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -7.8%5Y ort. ≈5.3% | ≈5.3% | -833.9% | En üst düzey | |
| FAVÖK Marjı (TTM) | -4.4%5Y ort. ≈6.2% | ≈6.2% | -475.2% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -7.6%5Y ort. ≈5.1% | ≈5.1% | -1646.3% | En üst düzey | |
| Net Kâr Marjı (TTM) | -18.4%5Y ort. ≈3.7% | ≈3.7% | -1223.2% | En üst düzey | |
| ROA (TTM) | -19.4%5Y ort. ≈3.8% | ≈3.8% | -34.3% | En üst düzey | |
| ROE (TTM) | -44.1%5Y ort. ≈7.2% | ≈7.2% | -39.3% | En üst düzey | |
| ROIC | 11.7%5Y ort. ≈6.8% | ≈6.8% | -44.2% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ORGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.55Y ort. ≈3.1 | ≈3.1 | 8.6 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 3.15Y ort. ≈2.7 | ≈2.7 | 7.8 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ORGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 17.0%5Y ort. ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 7.8%5Y ort. ≈5.8% | ≈5.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 10.8% | · | · | · | |
| EPS YoY (EPS YB) | -66.7%5Y ort. ≈72.4% | ≈72.4% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 4201.1%5Y ort. ≈882.7% | ≈882.7% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 7.7% | · | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | 0.00% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 33.6%5Y ort. ≈-26.5% | ≈-26.5% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 16.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ORGO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.05Y ort. ≈1.0 | ≈1.0 | 0.0 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 3.45Y ort. ≈4.6 | ≈4.6 | 22.2 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$660.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-11.3%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-0.73 | $-0.36 | -104.5% |
| 31 Mart 2026 | May 7, 2026 | $-0.41 | $-0.32 | -29.7% |
| 31 Aralık 2025 | $0.31 | $0.21 | 44.7% | |
| 30 Eylül 2025 | $0.15 | $0.06 | 167.4% | |
| 30 Haziran 2025 | $-0.10 | $-0.06 | -73.0% | |
| 31 Mart 2025 | $-0.10 | $-0.06 | -73.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Cost of Revenue | · | $116M | $106M | $105M | $114M | $87M | $76M | $69M | $61M | $48M | |
| Gross Profit | · | $366M | $327M | $346M | $353M | $251M | $185M | $125M | $137M | $91M | |
| R&D Expense | $45M | $50M | $44M | $40M | $31M | $20M | $15M | $11M | $9M | $6M | |
| SG&A Expense | $326M | $295M | $270M | $284M | $250M | $204M | $200M | $162M | $134M | $93M | |
| Operating Expenses | $519M | $483M | $421M | $324M | $281M | $224M | $215M | $176M | $143M | $99M | |
| Operating Income | $45M | $-1M | $13M | $22M | $72M | $27M | $-30M | $-52M | $-5M | $-9M | |
| Interest Expense | · | · | $2M | $2M | $7M | $11M | $9M | $11M | $8M | $6M | |
| Interest Income | · | · | · | · | · | · | · | $64.0K | $129.0K | $153.0K | |
| Other Non-op | $-5.0K | $20.0K | $57.0K | $-13.0K | $-13.0K | $97.0K | $13.0K | $162.0K | $-9.0K | $285.0K | |
| Pretax Income | $47M | $-3M | $10M | $20M | $63M | $18M | $-39M | $-65M | $-15M | $-15M | |
| Income Tax | $10M | $-4M | $5M | $5M | $-31M | $530.0K | $150.0K | $84.0K | $-7M | $65.0K | |
| Net Income | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.42 | $-0.94 | · | · | |
| EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | · | · | |
| Shares (Basic) | 126,738,136 | 131,673,278 | 131,231,317 | 130,070,231 | 128,331,022 | 107,737,936 | 92,840,401 | 69,318,456 | · | · | |
| Shares (Diluted) | 130,248,412 | 131,673,278 | 132,746,727 | 132,383,152 | 133,662,659 | 111,360,831 | 92,840,401 | 69,318,456 | · | · | |
| EBITDA | $60M | · | $13M | $22M | · | · | · | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $94M | $136M | $104M | $102M | $114M | $84M | $60M | $21M | $2M | $1M | |
| Receivables | $217M | $110M | $82M | $89M | $82M | $57M | $39M | $34M | $28M | · | |
| Inventory | $30M | $26M | $28M | $25M | $25M | $28M | $23M | $13M | $14M | · | |
| Prepaid Expense | $18M | $14M | $10M | $5M | $5M | $5M | $3M | $2M | $4M | $395.8K | |
| Current Assets | $362M | $286M | $225M | $223M | $227M | $174M | $126M | $71M | $50M | $1M | |
| PP&E (Net) | $104M | $89M | $116M | $102M | $79M | $56M | $47M | $40M | $42M | · | |
| PP&E (Gross) | $165M | $140M | $130M | $100M | $89M | $88M | $83M | $79M | $79M | · | |
| Accum. Depreciation | $88M | $73M | $73M | $63M | $58M | $74M | $66M | $62M | $59M | · | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $26M | $26M | $26M | · | |
| Intangibles | $9M | $12M | $16M | $21M | $26M | $31M | $21M | $26M | $30M | · | |
| Other Non-current Assets | $9M | $5M | $6M | $2M | $2M | $670.0K | $884.0K | $579.0K | $735.0K | · | |
| Total Assets | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Accounts Payable | $32M | $29M | $31M | $32M | $29M | $23M | $28M | $19M | $19M | · | |
| Accrued Liabilities | $50M | $39M | $30M | $26M | $37M | $24M | $23M | $20M | $23M | $50.8K | |
| Short-term Debt | · | · | · | · | · | · | $0 | $3M | $0 | · | |
| Current Liabilities | $100M | $77M | $81M | $75M | $83M | $68M | $60M | $56M | $52M | $478.4K | |
| Capital Leases | $22M | $25M | $25M | $21M | $47M | $0 | $14M | $15M | $12M | · | |
| Other Non-current Liabilities | $1M | $894.0K | $1M | $1M | $2M | $8M | $7M | $6M | $2M | · | |
| Total Liabilities | $165M | $113M | $181M | $184M | $202M | $148M | $165M | $117M | $157M | $11M | |
| Long-term Debt | · | · | $67M | $71M | $74M | $70M | · | · | $52M | · | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $9.0K | $6.0K | · | |
| Paid-in Capital | · | · | · | · | · | $297M | · | · | · | · | |
| Retained Earnings | $-3M | $-40M | $-41M | $-45M | $-61M | $-155M | $-171M | $-130M | $-65M | $-233.9K | |
| Stockholders' Equity | $300M | $263M | $279M | $266M | $241M | $142M | $52M | $40M | $-15M | $-16M | |
| Liabilities + Equity | $599M | $498M | $460M | $449M | $443M | $290M | $221M | $164M | $149M | $311M | |
| Shares Outstanding | 126,951,876 | 125,730,236 | 131,316,396 | 130,919,129 | 128,680,192 | 127,731,833 | 104,870,886 | 91,261,413 | 66,983,139 | 63,872,058 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $10M | $6M | · | · | · | · | · | · | |
| Stock-based Comp | $13M | $11M | $9M | $7M | $4M | $2M | $936.0K | $1M | $919.0K | $473.0K | |
| Deferred Tax | $10M | $-11M | $2M | $2M | $-32M | $112.0K | $111.0K | $186.0K | $-7M | · | |
| Amort. of Intangibles | $3M | $3M | $5M | $5M | $5M | $4M | $6M | $4M | $2M | $2M | |
| Restructuring | $516.0K | $0 | $4M | $2M | $5M | $618.0K | · | · | · | · | |
| Other Non-cash | $-85M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $14M | $31M | $25M | $62M | $5M | $-34M | $-61M | $-3M | $-5M | |
| CapEx | $14M | $10M | $24M | $34M | $31M | $18M | $6M | $2M | $2M | $1M | |
| Investing Cash Flow | $-14M | $-10M | $-24M | $-34M | $-31M | $-23M | $-6M | $-2M | $-15M | $-1M | |
| Stock Issued | · | · | · | · | · | $65M | $50M | $92M | · | $304M | |
| Stock Repurchased | · | $25M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $304M | |
| Financing Cash Flow | $-17M | $28M | $-6M | $-2M | $-1M | $42M | $79M | $82M | $19M | $7M | |
| Net Change in Cash | $-42M | $32M | $1M | $-11M | $30M | $24M | $39M | $19M | $500.0K | $659.0K | |
| Taxes Paid | $5M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-24M | · | $7M | $-9M | · | · | · | · | · | · | |
| Levered FCF | · | · | $6M | $-11M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 75.4% | 76.7% | · | · | · | · | · | · | |
| Operating Margin | 7.9% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| Net Margin | 6.6% | · | 1.1% | 3.4% | · | · | · | · | · | · | |
| Pretax Margin | 8.3% | · | 2.4% | 4.5% | · | · | · | · | · | · | |
| EBITDA Margin | 10.6% | · | 2.9% | 5.0% | · | · | · | · | · | · | |
| ROA | 6.8% | · | 1.1% | 3.5% | · | · | · | · | · | -0.13% | |
| ROE | 13.9% | · | 1.8% | 5.9% | · | · | · | · | · | -4.9% | |
| ROIC | 11.7% | · | 2.1% | 6.4% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | · | 2.8 | 3.0 | · | · | · | · | · | 3.0 | |
| Quick Ratio | 3.1 | · | 2.3 | 2.6 | · | · | · | · | · | 2.2 | |
| Interest Coverage | · | · | 5.7 | 11.1 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | · | 1.0 | 1.0 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | · | 4.0 | 4.2 | · | · | · | · | · | · | |
| Receivables Turnover | 3.4 | · | 5.1 | 5.2 | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.36 | · | $2.12 | $2.03 | · | · | · | · | · | $0.54 | |
| Revenue / Share | $4.33 | · | $3.26 | $3.41 | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.08 | · | $0.23 | $0.19 | · | · | · | · | · | · | |
| Cash / Share | $0.74 | · | $0.79 | $0.78 | · | · | · | · | · | $0.11 | |
| EPS (TTM) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 | $-0.13 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.0% | 11.3% | -3.9% | -3.5% | 38.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.8% | 1.0% | 8.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -66.7% | -82.9% | 366.7% | · | · | · | · | · | |
| EPS CAGR 3Y | 7.7% | · | -35.6% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 0.00% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4201.1% | -82.6% | -68.2% | -83.5% | 446.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 33.6% | -79.1% | -34.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 16.5% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $564M | $482M | $433M | $451M | $467M | $338M | $261M | $193M | $199M | $139M | |
| Net Income TTM | $37M | $861.0K | $5M | $16M | $94M | $17M | $-39M | $-65M | $-8M | $-17M | |
| Market Cap | $658M | · | $537M | $352M | · | · | · | · | · | · | |
| P/E | 34.5 | -320.0 | 102.2 | 22.4 | 13.2 | 50.2 | -11.5 | -10.8 | -76.3 | · | |
| P/S | 1.2 | · | 1.2 | 0.8 | · | · | · | · | · | · | |
| P/B | 2.2 | · | 1.9 | 1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 2.5 | 1.8 | 2.3 | 1.6 | 6.4 | 11.7 | · | · | · | · | |
| P / Cash Flow | -63.8 | · | 17.4 | 14.2 | · | · | · | · | · | · | |
| P / FCF | -26.9 | · | 82.0 | -39.0 | · | · | · | · | · | · | |
| Earnings Yield | 2.9% | -0.31% | 0.98% | 4.5% | 7.6% | 2.0% | -8.7% | -9.3% | -1.3% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44M | $37M | $226M | $151M | $101M | $87M | $127M | $115M | $130M | $110M | $100M | $109M | $117M | $108M | $116M | $117M | |
| Cost of Revenue | · | · | · | · | · | $24M | · | $27M | $29M | $29M | · | $26M | $26M | $27M | $27M | $26M | |
| Gross Profit | · | · | · | · | · | $63M | · | $88M | $101M | $81M | · | $83M | $91M | $81M | $88M | $91M | |
| R&D Expense | $18M | $15M | $10M | $13M | $10M | $11M | $12M | $10M | $16M | $13M | $12M | $10M | $11M | $11M | $11M | $10M | |
| SG&A Expense | $54M | $65M | $100M | $80M | $74M | $73M | $74M | $72M | $77M | $72M | $61M | $64M | $70M | $74M | $68M | $79M | |
| Operating Expenses | $95M | $106M | $186M | $130M | $114M | $113M | $145M | $109M | $144M | $85M | $180M | $75M | $81M | $85M | $80M | $89M | |
| Operating Income | $-51M | $-69M | $63M | $21M | $-13M | $-27M | $10M | $6M | $-14M | $-4M | $-1M | $8M | $10M | $-4M | $9M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $620.0K | $514.0K | · | $444.0K | $594.0K | $649.0K | · | $572.0K | |
| Other Non-op | $-26.0K | $38.0K | $-98.0K | $18.0K | $73.0K | $2.0K | $-27.0K | $52.0K | $-28.0K | $23.0K | $-25.0K | $31.0K | $28.0K | $23.0K | $6.0K | $5.0K | |
| Pretax Income | $-51M | $-68M | $63M | $21M | $-12M | $-26M | $10M | $6M | $-15M | $-4M | $-2M | $8M | $9M | $-5M | $9M | $1M | |
| Income Tax | $45M | $-15M | $20M | $-407.0K | $-2M | $-7M | $3M | $-7M | $3M | $-2M | $-1M | $4M | $4M | $-2M | $1M | $997.0K | |
| Net Income | $-96M | $-53M | $44M | $22M | $-9M | $-19M | $8M | $12M | $-17M | $-2M | $-569.0K | $3M | $5M | $-3M | $7M | $215.0K | |
| EPS (Basic) | $-0.77 | $-0.44 | $0.32 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| EPS (Diluted) | $-0.77 | $-0.44 | $0.31 | $0.11 | $-0.10 | $-0.17 | $0.05 | $0.09 | $-0.13 | $-0.02 | $0.00 | $0.02 | $0.04 | $-0.02 | $0.06 | $0.00 | |
| Shares (Basic) | 128,674,548 | 127,797,013 | · | 126,881,709 | 126,853,536 | 126,295,642 | · | 132,575,301 | 132,573,153 | 131,861,772 | · | 131,312,483 | 131,293,398 | 131,083,841 | · | 130,903,160 | |
| Shares (Diluted) | 128,674,548 | 127,797,013 | · | 130,848,995 | 126,853,536 | 126,295,642 | · | 133,926,755 | 132,573,153 | 131,861,772 | · | 133,417,721 | 133,066,010 | 131,083,841 | · | 132,232,954 | |
| EBITDA | $-51M | $-65M | · | $21M | $-13M | $-23M | · | $10M | $-11M | $-4M | · | $8M | $10M | $-4M | · | $2M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $91M | $94M | $64M | $73M | $110M | $136M | $94M | $90M | $89M | · | $98M | $89M | $89M | · | $107M | |
| Receivables | $101M | $117M | $217M | $169M | $120M | $103M | $110M | $101M | $106M | $96M | · | $89M | $94M | $92M | · | $93M | |
| Inventory | $29M | $28M | $30M | $40M | $33M | $29M | $26M | $27M | $27M | $28M | · | $28M | $25M | $26M | · | $25M | |
| Prepaid Expense | $20M | $29M | $18M | $23M | $28M | $18M | $14M | $15M | $11M | $14M | · | $10M | $8M | $10M | · | $5M | |
| Current Assets | $200M | $269M | $362M | $300M | $260M | $268M | $286M | $239M | $234M | $227M | · | $226M | $216M | $217M | · | $231M | |
| PP&E (Net) | $102M | $104M | $104M | $78M | $76M | $76M | $89M | $90M | $90M | $114M | · | $118M | $112M | $107M | · | $97M | |
| PP&E (Gross) | · | · | $165M | $135M | $132M | $128M | $140M | $144M | $146M | $131M | · | $128M | $119M | $116M | · | $99M | |
| Accum. Depreciation | · | · | $88M | $84M | $80M | $76M | $73M | $75M | $75M | $75M | · | $70M | $68M | $65M | · | $62M | |
| Goodwill | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | $29M | · | $29M | $29M | $29M | · | $29M | |
| Intangibles | $3M | $3M | $9M | $10M | $11M | $12M | $12M | $13M | $14M | $15M | · | $17M | $18M | $20M | · | $22M | |
| Other Non-current Assets | $23M | $16M | $9M | $14M | $9M | $6M | $5M | $5M | $6M | $7M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Accounts Payable | $29M | $29M | $32M | $40M | $30M | $25M | $29M | $24M | $29M | $23M | · | $27M | $27M | $30M | · | $38M | |
| Accrued Liabilities | · | · | $50M | $40M | $26M | $31M | $39M | $36M | $38M | $40M | · | $35M | $28M | $29M | · | $34M | |
| Current Liabilities | $57M | $76M | $100M | $90M | $66M | $65M | $77M | $77M | $86M | $83M | · | $81M | $73M | $76M | · | $89M | |
| Capital Leases | $21M | $22M | $22M | $24M | $25M | $26M | $25M | $23M | $23M | $24M | · | $39M | $40M | $40M | · | $43M | |
| Other Non-current Liabilities | $4M | $1M | $1M | $3M | $3M | $897.0K | $894.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $118M | $139M | $165M | $124M | $100M | $99M | $113M | $168M | $180M | $180M | · | $186M | $179M | $182M | · | $201M | |
| Long-term Debt | · | · | · | · | · | · | · | $62M | $64M | $65M | · | $68M | $69M | $70M | · | $73M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | · | $13.0K | $13.0K | $13.0K | · | $13.0K | |
| Retained Earnings | $-153M | $-56M | $-3M | $-47M | $-68M | $-59M | $-40M | $-48M | $-60M | $-43M | · | $-40M | $-44M | $-49M | · | $-53M | |
| Stockholders' Equity | $148M | $245M | $300M | $255M | $233M | $243M | $263M | $279M | $264M | $278M | $279M | $277M | $271M | $264M | $266M | $256M | |
| Liabilities + Equity | $406M | $520M | $599M | $510M | $461M | $467M | $498M | $446M | $443M | $458M | · | $463M | $450M | $446M | · | $457M | |
| Shares Outstanding | 128,674,548 | 128,674,548 | 126,951,876 | 126,911,442 | 126,853,536 | 126,853,536 | 125,730,236 | 132,576,502 | 132,574,238 | 132,539,340 | 131,316,396 | 131,312,616 | 131,311,852 | 131,226,387 | 130,919,129 | 130,915,099 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $45M | $-15M | $16M | $-4M | $-1M | $-1M | $-3M | $-2M | · | · | $2M | · | · | · | · | · | |
| Amort. of Intangibles | $433.0K | $6M | $798.0K | $842.0K | $841.0K | $842.0K | $834.0K | $834.0K | $834.0K | $901.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $96.0K | $-126.0K | $2M | $750.0K | $611.0K | |
| Other Non-cash | · | $82M | · | · | · | $-7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $21M | $39M | $3M | $-33M | $-20M | $11M | $9M | $5M | $-10M | $11M | $17M | $9M | $-5M | $8M | $5M | |
| CapEx | $1M | $3M | $5M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $6M | $7M | $8M | $11M | $10M | |
| Investing Cash Flow | $-1M | $-3M | $-5M | $-2M | $-4M | $-4M | $-3M | $-3M | $-2M | $-2M | $-3M | $-6M | $-7M | $-8M | $-11M | $-10M | |
| Financing Cash Flow | $-13M | $-20M | $-5M | $-10M | $-288.0K | $-2M | $34M | $-2M | $-2M | $-3M | $-2M | $-1M | $-1M | $-1M | $-2M | $26.0K | |
| Net Change in Cash | $-45M | $-2M | $30M | $-9M | $-37M | $-26M | $41M | $4M | $1M | $-15M | $6M | $9M | $93.0K | $-14M | $-5M | $-5M | |
| Free Cash Flow | · | $18M | · | · | · | $-24M | · | · | · | $-12M | · | · | · | $-13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-13M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 72.6% | · | 76.7% | 77.6% | 73.9% | · | 76.2% | 77.6% | 75.3% | · | 77.6% | |
| Operating Margin | -116.5% | -185.1% | · | 13.7% | -12.4% | -30.9% | · | 5.4% | -10.7% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| Net Margin | -220.0% | -142.8% | · | 14.3% | -9.3% | -21.7% | · | 10.7% | -13.1% | -1.9% | · | 2.9% | 4.5% | -2.8% | · | 0.18% | |
| Pretax Margin | -116.3% | -183.9% | · | 14.0% | -11.7% | -29.7% | · | 5.1% | -11.2% | -4.0% | · | 7.0% | 7.8% | -4.3% | · | 1.0% | |
| EBITDA Margin | -116.5% | -173.8% | · | 13.7% | -12.4% | -26.9% | · | 8.5% | -8.1% | -3.5% | · | 7.4% | 8.3% | -3.7% | · | 1.5% | |
| ROA | -22.2% | -10.8% | · | 4.5% | -2.1% | -4.1% | · | 2.7% | -3.8% | -0.46% | · | 0.69% | 1.2% | -0.67% | · | 0.05% | |
| ROE | -50.5% | -21.8% | · | 8.1% | -3.8% | -7.2% | · | 4.4% | -6.4% | -0.78% | · | 1.2% | 2.0% | -1.2% | · | 0.10% | |
| ROIC | -65.1% | -21.9% | · | 8.3% | -4.3% | -8.1% | · | 4.8% | -6.2% | -0.67% | · | 1.2% | 2.1% | -0.97% | · | 0.12% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.5 | · | 3.3 | 4.0 | 4.1 | · | 3.1 | 2.7 | 2.7 | · | 2.8 | 2.9 | 2.9 | · | 2.6 | |
| Quick Ratio | 2.6 | 2.7 | · | 2.6 | 2.9 | 3.3 | · | 2.5 | 2.3 | 2.2 | · | 2.3 | 2.5 | 2.4 | · | 2.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -22.4 | -7.5 | · | 18.1 | 16.4 | -6.2 | · | 3.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Inventory Turnover | · | · | · | · | · | 0.8 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | |
| Receivables Turnover | 0.4 | 0.3 | · | 1.1 | 0.9 | 0.9 | · | 1.2 | 1.3 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $1.90 | · | $2.01 | $1.84 | $1.91 | · | $2.10 | $1.99 | $2.10 | · | $2.11 | $2.07 | $2.01 | · | $1.96 | |
| Revenue / Share | $0.34 | $0.29 | · | $1.15 | $0.80 | $0.69 | · | $0.86 | $0.98 | $0.83 | · | $0.81 | $0.88 | $0.82 | · | $0.88 | |
| Cash Flow / Share | · | $0.17 | · | · | · | $-0.16 | · | · | · | $-0.08 | · | · | · | $-0.04 | · | · | |
| Cash / Share | $0.36 | $0.71 | · | $0.50 | $0.58 | $0.87 | · | $0.71 | $0.68 | $0.67 | · | $0.75 | $0.68 | $0.68 | · | $0.82 | |
| EPS (TTM) | $-0.79 | $-0.12 | · | $-0.11 | $-0.13 | $-0.16 | · | $-0.06 | $-0.13 | $0.04 | · | $0.10 | $0.08 | $0.11 | · | $0.45 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $457M | $515M | · | $465M | $430M | $459M | · | $455M | $448M | $435M | · | $449M | $457M | $461M | · | $463M | |
| Net Income TTM | $-84M | $3M | · | $1M | $-8M | $-16M | · | $-7M | $-17M | $6M | · | $13M | $10M | $13M | · | $59M | |
| Market Cap | $313M | $305M | · | $536M | $464M | $548M | · | $379M | $371M | $376M | · | $418M | $436M | $280M | · | $424M | |
| P/E | -3.1 | -19.8 | · | -38.4 | -28.2 | -27.0 | · | -47.7 | -21.5 | 71.0 | · | 31.8 | 41.5 | 19.4 | · | 7.2 | |
| P/S | 0.7 | 0.6 | · | 1.2 | 1.1 | 1.2 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 1.0 | 0.6 | · | 0.9 | |
| P/B | 2.1 | 1.2 | · | 2.1 | 2.0 | 2.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.1 | · | 1.7 | |
| P / Tangible Book | 2.7 | 1.4 | · | 2.5 | 2.4 | 2.7 | · | 1.6 | 1.7 | 1.6 | · | 1.8 | 1.9 | 1.3 | · | 2.1 | |
| P / Cash Flow | · | 14.4 | · | · | · | -27.5 | · | · | · | -37.0 | · | · | · | -55.1 | · | · | |
| Earnings Yield | -32.5% | -5.1% | · | -2.6% | -3.5% | -3.7% | · | -2.1% | -4.6% | 1.4% | · | 3.1% | 2.4% | 5.2% | · | 13.9% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $564M | $482M | $433M | $451M | $467M |
| Brüt Kâr Marjı % | · | · | 75.4% | 76.7% | · |
| Faaliyet Kâr Marjı % | 7.9% | · | 2.9% | 5.0% | · |
| Net Gelir | $37M | $861.0K | $5M | $16M | $94M |
| Seyreltilmiş Hisse Başı Kâr | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 3.6 | · | 2.8 | 3.0 | · |
| Cari Oran | 3.1 | · | 2.3 | 2.6 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-24M | · | $7M | $-9M | · |
Kurumsal Sahipler (13F) 140 dosya · $179.8M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
140
Tutulan Değer
$179.8M
Yeni pozisyonlar
32
Çıkan pozisyonlar
14
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 32 (+14 önceki Ç'ye göre) | 14 (-26 önceki Ç'ye göre) | 52 (+20 önceki Ç'ye göre) | 33 (-13 önceki Ç'ye göre) | +4.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| MORGAN STANLEY | $28.483.510 | 11.721.609 | 15,84% | Hisse senetleri |
| VANGUARD GROUP INC | $25.686.978 | 4.958.876 | 14,28% | Hisse senetleri |
| Soleus Capital Management, L.P. | $24.642.511 | 10.140.951 | 13,70% | Hisse senetleri |
| BlackRock, Inc. | $17.616.354 | 7.249.528 | 9,80% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $7.412.123 | 3.050.297 | 4,12% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $7.318.559 | 3.011.753 | 4,07% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.061.383 | 2.905.919 | 3,93% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $7.018.601 | 2.888.313 | 3,90% | Hisse senetleri |
| Assenagon Asset Management S.A. | $4.782.123 | 1.967.952 | 2,66% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $4.704.612 | 1.935.554 | 2,62% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $4.146.032 | 1.706.186 | 2,31% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.906.781 | 1.607.729 | 2,17% | Hisse senetleri |
| STATE STREET CORP | $3.693.491 | 1.519.955 | 2,05% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $2.471.585 | 1.017.113 | 1,37% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.199.208 | 905.024 | 1,22% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $2.156.380 | 887.399 | 1,20% | Hisse senetleri |
| CITADEL ADVISORS LLC | $2.109.067 | 867.929 | 1,17% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.682.039 | 692.197 | 0,94% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $1.527.741 | 628.700 | 0,85% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.420.522 | 584.577 | 0,79% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $1.368.206 | 563.048 | 0,76% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $1.336.500 | 550.000 | 0,74% | Hisse senetleri |
| NORGES BANK | $1.290.087 | 530.900 | 0,72% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.203.732 | 495.363 | 0,67% | Hisse senetleri |
| FLAX POND CAPITAL, LLC | $1.026.896 | 422.591 | 0,57% | Hisse senetleri |
| UBS Group AG | $871.661 | 358.708 | 0,48% | Hisse senetleri |
| Bank of New York Mellon Corp | $776.732 | 319.643 | 0,43% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $755.154 | 310.763 | 0,42% | Hisse senetleri |
| Squarepoint Ops LLC | $613.881 | 252.626 | 0,34% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $556.067 | 228.834 | 0,31% | Hisse senetleri |
| FMR LLC | $523.944 | 215.615 | 0,29% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $498.667 | 205.213 | 0,28% | Hisse senetleri |
| Nuveen, LLC | $469.488 | 193.205 | 0,26% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $454.354 | 186.977 | 0,25% | Hisse senetleri |
| XTX Topco Ltd | $446.537 | 183.760 | 0,25% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $419.586 | 172.669 | 0,23% | Hisse senetleri |
| Invesco Ltd. | $410.437 | 168.904 | 0,23% | Hisse senetleri |
| BARCLAYS PLC | $394.780 | 162.461 | 0,22% | Hisse senetleri |
| Wealth Dimensions Group, Ltd. | $369.968 | 152.250 | 0,21% | Hisse senetleri |
| Mariner, LLC | $358.977 | 147.731 | 0,20% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $351.769 | 144.761 | 0,20% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $351.518 | 148.320 | 0,20% | Hisse senetleri |
| HSBC HOLDINGS PLC | $323.561 | 139.166 | 0,18% | Hisse senetleri |
| Cerity Partners LLC | $310.018 | 127.579 | 0,17% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $239.445 | 98.537 | 0,13% | Hisse senetleri |
| RHUMBLINE ADVISERS | $208.147 | 85.660 | 0,12% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $205.943 | 84.750 | 0,11% | Hisse senetleri |
| Creative Planning | $205.160 | 84.428 | 0,11% | Hisse senetleri |
| State of Wyoming | $203.738 | 83.843 | 0,11% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $181.577 | 75.657 | 0,10% | Hisse senetleri |
Aktivistler ve %5+ sahipler 5 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Glenn H. Nussdorf, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 03 Kasım 2025 | 9,70% | Değişiklik | · | SEC |
| Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom, Organo PFG LLC, Organo Investors LLC, Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, Dennis Erani 2012 Issue Trust dated 12/20/12, GN 2016 Family Trust u/a/d August 12, 2016, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, RED Holdings, LLC, Josette Ades ×11 başvurular | 26 Haziran 2025 | 17,60% | Değişiklik | · | SEC |
| Avista Healthcare Partners III, L.P., AHP III Orchestra Holdings, L.P., Avista Capital Partners VI GP, L.P., Avista Capital Managing Member VI, LLC, Thompson Dean, David Burgstahler | 19 Kasım 2024 | · | İlk başvuru | Pasif yatırım | SEC |
| Avista Acquisition Corp., Avista Acquisition, LLC, Avista Capital Partners (Offshore) IV, LP, Avista Capital Partners IV, L.P., Avista Capital Managing Member IV, LLC, Avista Capital Partners IV GP L.P., Thompson Dean, David Burgstahler ×6 başvurular | 27 Mayıs 2021 | · | İlk başvuru | · | SEC |
| Avista Acquisition Corp. (2), Avista Acquisition, LLC. (2), Avista Capital Partners (Offshore) IV, LP (2), Avista Capital Partners IV, L.P. (2), Avista Capital Managing Member IV, LLC (2), Avista Capital Partners, IV GP L.P. (2), Thompson Dean (2), David Burgstahler (2) | 20 Aralık 2018 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 27 içeriden öğrenenler · 10 yöneticiler · 15 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Gary S. Gillheeney | President and CEO | 18 Şubat 2026 F | 4.232.087 | 0 | 0 | $0 |
| David Francisco | Chief Financial Officer | 18 Şubat 2026 F | 731.312 | 0 | 0 | $0 |
| Henry Hagopian III | Interim CFO | 13 Ocak 2021 A | 12.073 | 0 | 0 | $0 |
| Timothy M. Cunningham | Chief Financial Officer | 22 Nisan 2020 A | 27.847 | 0 | 0 | $0 |
| Patrick Bilbo | Chief Operating Officer | 18 Şubat 2026 F | 1.128.312 | 0 | 0 | $0 |
| Robert Cavorsi | Vice President, Strategy | 01 Mart 2026 F | 275.524 | 0 | 0 | $0 |
| Antonio S. Montecalvo | Vice President, Health Policy | 18 Şubat 2026 F | 226.238 | 0 | 0 | $0 |
| Lori Freedman | Chief Admin. and Legal Officer | 18 Şubat 2026 F | 1.023.643 | 0 | 0 | $0 |
| Brian Grow | Chief Commercial Officer | 10 Ocak 2025 M | 900.682 | 0 | 0 | $0 |
| Howard Walthall | Exec. VP, Strat. & Mkt Dev. | 10 Aralık 2018 A | · | 0 | 0 | $0 |
| Michael Joseph Driscoll | Yönetim kurulu üyesi | 09 Mart 2026 P | 225.707 | 1 | 0 | $26.700 |
| Arthur S Leibowitz | Yönetim kurulu üyesi | 09 Mart 2026 P | 291.014 | 1 | 0 | $13.400 |
| Garrett Lustig | Yönetim kurulu üyesi | 18 Şubat 2026 A | 125.742 | 0 | 0 | $0 |
| Gilberto Quintero | Yönetim kurulu üyesi | 18 Şubat 2026 A | 239.073 | 0 | 0 | $0 |
| Prathyusha Duraibabu | Yönetim kurulu üyesi | 18 Şubat 2026 A | 247.047 | 0 | 0 | $0 |
| Michele Ilene Korfin | Yönetim kurulu üyesi | 18 Şubat 2026 A | 239.073 | 0 | 0 | $0 |
| Jon L Giacomin | Yönetim kurulu üyesi | 18 Şubat 2026 A | 241.026 | 0 | 0 | $0 |
| Glenn H. Nussdorf | Yönetim kurulu üyesi | 16 Aralık 2025 S | 2.565.591 | 2 | 6 | $-1.603.954 |
| Joshua Alexander Tamaroff | Yönetim kurulu üyesi | 16 Şubat 2021 A | 30.364 | 0 | 0 | $0 |
| Wayne D Mackie | Yönetim kurulu üyesi | 16 Şubat 2021 A | 211.800 | 0 | 0 | $0 |
| Robert P O'Neil | Yönetim kurulu üyesi | 10 Aralık 2018 D | · | 0 | 0 | $0 |
| Charles C Harwood Jr | Yönetim kurulu üyesi | 10 Aralık 2018 D | · | 0 | 0 | $0 |
| Hakan Bjorklund | Yönetim kurulu üyesi | 10 Aralık 2018 D | · | 0 | 0 | $0 |
| Brian A Markison | Yönetim kurulu üyesi | 10 Aralık 2018 D | · | 0 | 0 | $0 |
| Michael W Katz | 10% sahip | 21 Kasım 2022 P | 76.382 | 0 | 0 | $0 |
| Dennis Erani | 10% sahip | 27 Mayıs 2021 S | 1.314.517 | 0 | 0 | $0 |
| Starr Wisdom | 10% sahip | 09 Nisan 2021 S | 20.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 22 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 49.635 SH | 19 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,03% | 239.111 SH | 11 Eylül 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,02% | 79.308 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 396.742 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 60.177 SH | 19 Ağustos 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,01% | 267.878 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 129.858 SH | 02 Ekim 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 33.027 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 295.905 NS | 31 Temmuz 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 221.009 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.771.226 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 4.647 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 205.812 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 9.772 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 22.383 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 31.880 SH | 09 Eylül 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,00% | 9.630 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 848.524 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.991.446 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.493 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 189.815 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 625.359 SH | 11 Eylül 2026 | Günlük |
ORGO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
SAT
Medyan hedef
$2.00
+50,4%
0 0,0%
Güçlü Al
0 0,0%
Al
4 57,1%
Tut
1 14,3%
Sat
2 28,6%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-10-04Ortalama hedef $2.00 +50,4%
Düşük$2.00
Ortalama$2.00
Yüksek$2.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026